Notable Insider Trading: Reata Pharmaceuticals, Inc. $RETA

17b37123399013b9b2877502bc8edc98

Reata Pharmaceuticals, Inc. (RETA) insiders have most recently took part in a trading activity. On Dec 29, 2017 Traweek James W Jr, 10% Owner bought 17,000 shares having total worth of $483,990 at the price of $28.47 per share, following the transaction a total of 2,940,142 shares owned by Traweek James W Jr. Before this latest buy, Traweek James W Jr purchased RETA at 3 other times during the past twelve months, for a total investment of $58.67M at an average of $24.15 per share.

On the same day, Mcgaughy R Kent Jr, Director, 10% Owner bought 17,000 shares having total worth of $483,990 at the price of $28.47 per share, following the transaction a total of 2,945,137 shares owned by Mcgaughy R Kent Jr. Before this latest buy, Mcgaughy R Kent Jr purchased RETA at 3 other times during the past twelve months, for a total investment of $58.67M at an average of $24.15 per share.

On the same day, Cpmg Inc, Director, 10% Owner bought 17,000 shares having total worth of $483,990 at the price of $28.47 per share, following the transaction a total of 2,912,523 shares owned by Cpmg Inc. Before this latest buy, Cpmg Inc purchased RETA at 4 other times during the past twelve months, for a total investment of $67.32M at an average of $24.31 per share.

The stock has experienced a total of 8 insider trades in the past three months. These trades include 8 buy trades. Furthermore, over the past 12 months , the stock was traded 16 times by insiders. In 4 of these trades, the insider was a seller while an employee of the company was the buyer in 12 instances.

Time Frame Number of Insider Buy Number of Insider Sell Stock Price Change(%)
3 Month 8 0 2.55%
12 Month 12 4 55.39%

Shares of Reata Pharmaceuticals, Inc. (RETA) traded up 4.86% on Dec 28, 2017, hitting $26.96. 152,166 shares of the company’s stock traded hands. Reata Pharmaceuticals, Inc. has a 52 week low of $15.51 and a 52 week high of $36.11. The company’s market cap is $0 million.

Reata Pharmaceuticals, Inc. (RETA) last announced its earnings results on Nov 13, 2017. The company reported -0.50 earnings per share (EPS) for the quarter, lower than the consensus estimate of -0.41 by $0.09. The company had revenue of $13 million for the quarter, compared to the consensus estimate of $13 million. During the same quarter in the previous year, the company posted -0.04 earnings per share. The company’s revenue for the quarter was up 0% on a year-over-year basis.

2017-11-13 2017-08-14 2017-05-11 2017-03-03 2016-11-14 2016-08-11
earnings per share -0.50 -0.52 -0.32 -0.19 -0.04 -0.05
Revenue(M) 12.56 12.81 12.73 12.5 12.55 12.37

William White

William White is a financial writer. He graduated with a degree in Economics. He has contributed to major financial websites and print publications for over 8 years. He handles much of this site's news coverage for corporate insider activity, and occasionally cover other areas of financial sector.

About the Author

William White
William White is a financial writer. He graduated with a degree in Economics. He has contributed to major financial websites and print publications for over 8 years. He handles much of this site's news coverage for corporate insider activity, and occasionally cover other areas of financial sector.